Industry NewsLife Science
The RegistryJune 30, 20232 Mins read876
Following Merger with East Coast Firm, Biotech Firm Decides to Locate HQ in Seattle
The RegistryJune 30, 20232 Mins read876
Share
By The Registry Staff
Clay Siegall, the co-founder and former CEO of Bothell-based biotech Seagen
Related Articles
Synergy Affiliate Buys Former Selig Site in Seattle for $5.3MM with Plans for 120-Unit Apartment Tower
Rex Modular, an affiliate of Synergy Construction and Development, would use the...
Interstate Bridge Replacement Cost Estimate Soars to $14.4 Billion as Governors Commit to Phased Construction Strategy
Washington and Oregon leaders narrow initial focus to $7.65 billion core bridge...
City of Bellevue Grants Design Review Approval to Capstone Partners’ 27-Story, 328-Unit Residential Tower
The project, designed by Runberg Architecture Group and developed in partnership with...
Crest Holdings’ 491-Unit Apartment Proposal in Bellevue Met with Master Development and Design Review Approval
The LA-based developer’s master plan at 919 109th Avenue NE includes an...